Rankings
▼
Calendar
▼
TLX FY 1999 Earnings Report — Telix Pharmaceuticals Limited Revenue & Financial Results | Market Cap Arena
Telix Pharmaceuticals Limited
TLX
FY 1999 Earnings
Reported September 29, 1999
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
FY 1999
Prior Q
FY 1998
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$413.1K
—
—
—
—
EPS (Diluted)
$-0.01
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$0
Other Expenses
-$413.1K
Operating Expenses
-$413.1K
Cost & Expenses
-$413.1K
OPERATING INCOME
-$413.1K
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$206.5K
Income Tax Expense
-$206.5K
Net Income from Continuing Ops
-$206.5K
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$206.5K
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$206.5K
D&A
$0
EBIT
$0
EBITDA
-$413.1K
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
← Q4 1998
TLX Overview
Q2 1999 →